Pro Islet Amyloid Polypeptide (ProIAPP) Immunoreactivity in the Islets of Langerhans

References

• Badman, M.K. Sherman, K.I. Jermany, J.L. Docherty, K. Clark, A. Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2 FEBS Lett 1996 378 227–231.
   PubMed Web of Science ®Google Scholar
• Clark, A. Lloyd, J. Novials, A. Hutton, J.C. Morris, J.F. Localisation of islet amyloid polypeptide and its carboxy terminal flanking peptide in islets of diabetic man and monkey Diabetologia 1991 34 449–451.
   PubMed Web of Science ®Google Scholar
• Cooper, G.J. Willis, A.C. Clark, A. Turner, A.C. Sim, R.B. Reid, K.B. M. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients Proc Natl Acad Sci USA 1987 84 8628–8632.
   PubMed Web of Science ®Google Scholar
• Furuta, M. Carroll, R. Martin, S. Swift, H.H. Ravazzola, M. Orci, L. Steiner, D.F. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2 J Biol Chem 273 3431–3437.
   PubMed Web of Science ®Google Scholar
• Gebre-Medhin, S. Mulder, H. Pekny, M. Westermark, G.T. Törnell, J. Westermark, P. Sundler, F. Ahrén, B. Betsholtz, C. Increased insulin secretion and and glucose tolerance in mice lacking islet amyloid polypeptide (amylin) Biochem Biophys Res Commun 1998 250 271–277.
   PubMed Web of Science ®Google Scholar
• Gustavsson, Å. Engström, U. Westermark, P. Mechanisms of transthyretin (TTR) amyloidogenesis: Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations Am J Path 1994 144 1301–1311.
   PubMed Web of Science ®Google Scholar
• Hull, R.L. Jaikaran, E.T. Serpell, L.C. Fraser, P.E. Clark, A. Landon, M. Synthetic human pro-islet amyloid polypeptide forms amyloid-like fibrils in vitro Diabetologia 1998 41 Suppl. 1 A657 ( abstr).
   Google Scholar
• Janciauskiene, S. Eriksson, S. Carlemalm, E. Ahrén, B. B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro Biochem Biophys Res Commun 1997 236 580–585.
   PubMed Web of Science ®Google Scholar
• Janson, J. Ashley, R.H. Harrison, D. McIntyre, S. Butler, P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles Diabetes 1999 48 491–498.
   PubMed Web of Science ®Google Scholar
• Jarrett, J.T. Lansbury, P.T. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993 73 1055–1058.
   PubMed Web of Science ®Google Scholar
• Karlsson, E. IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion Int J Mol Med 1999 3 577–584.
   PubMed Web of Science ®Google Scholar
• Lipkind, G. Steiner, D.F. Predicted structural alterations in proinsulin during its interaction with prohormone convertases Biochemistry 1999 19 890–896.
   Google Scholar
• Lorenzo, A. Razzaboni, B. Weir, G.C. Yankner, B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus Nature 1994 368 756–760.
   PubMed Web of Science ®Google Scholar
• Ma, Z. Westermark, G.T. Li, Z.-C. Engström, U. Westermark, P. Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in the amyloidogenesis Diabetologia 1997 40 793–801.
   PubMed Web of Science ®Google Scholar
• Nishi, M. Bell, G.I. Steiner, D.F. Islet amyloid polypeptide (amylin): No evidence of an abnormal precursor sequence in 25 Type 2 (non-insulin-dependent) diabetic patients Diabetologia 1990 33 628–630.
   PubMed Web of Science ®Google Scholar
• Nishi, M. Sanke, T. Nagamatsu, S. Bell, G.I. Steinder, D.F. Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits J Biol Chem 1990 265 4173–4176.
   PubMed Web of Science ®Google Scholar
• O'Brien, T.D. Butler, A.E. Roche, P.C. Johnson, K.H. Butler, P.C. Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis Diabetes 1994 43 329–336.
   PubMed Web of Science ®Google Scholar
• Olsen, K.E. Sletten, K. Westermark, P. The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay Am J Clin Path 1999 111 355–362.
   PubMed Web of Science ®Google Scholar
• Puchtler, H. Sweat, F. Levine, M. On the binding of Congo red by amyloid J Histochem Cytochem 1962 10 355–364.
   Web of Science ®Google Scholar
• Sakagashira, S. Sanke, T. Hanabusa, T. Shimomura, H. Ohagi, S. Kumagaye, K.Y. Nakajima, K. Nanjo, K. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients Diabetes 1996.20 45 1279–1281.
   PubMed Web of Science ®Google Scholar
• Sletten, K. Westermark, P. Natvig, J.B. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid J Exp Med 1976 143 993–998.
   PubMed Web of Science ®Google Scholar
• Westermark, G.T. Johnson, K.H. Westermark, P. Staining Methods for Identification of Amyloid in Tissue Meth Enzymol 1999 309 3–25.
   PubMed Web of Science ®Google Scholar
• Westermark, G. Arora, BenigM. Fox, N. Carroll, R. Chan, S.J. Westermark, P. Steiner, D.F. Amyloid formation in response to b cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide Mol Med 1995 1 542–553.
   PubMed Web of Science ®Google Scholar
• Westermark, G.T. Gebre-Medhin, S. Steiner, D.F. Westermark, P. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP 2000 Submitted.
   Google Scholar
• Westermark, G.T. Westermark, P. Eizirik, D. Hellerström, C. Fox, N. Steiner, D.F. Andersson, A. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice Metabolism 1999 48 448–454.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A 1973 359 1–18.
   Google Scholar
• Westermark, P. Eizirik, D.L. Pipeleers, D.G. Hellerström, C. Andersson, A. Rapid deposition of amyloid in human islets transplanted into nude mice Diabetologia 1995 38 543–549.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Engström, U. Johnson, K.H. Westermark, G.T. Betsholtz, C. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation Proc Natl Acad Sci USA 1990 87 5036–5040.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Engström, U. Westermark, G.T. Johnson, K.H. Permerth, J. Betsholtz, C. Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans Diab Res Clin Pract 1989 7 219–226.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Li, Z.-C. Westermark, G.T. Leckström, A. Steiner, D.F. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation FEBS Lett 1996 379 203–206.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Wernstedt, C. O'Brien, T.D. Hayden, D.W. Johnson, K.H. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone Am J Path 1987 127 414–417.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Wernstedt, C. Wilander, E. Hayden, D.W. O'Brien, T.D. Johnson, K.H. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells Proc Natl Acad Sci USA 1987 84 3881–3885.
   PubMed Web of Science ®Google Scholar
• Westermark, P. Wernstedt, C. Wilander, E. Sletten, K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas Biochem Biophys Res Commun 1986 140 827–831.
   PubMed Web of Science ®Google Scholar